文献

J-GLOBAL ID：202102248681324152   整理番号：21A0137873

脂質異常症の治療に対する医薬品の臨床評価に関するガイドライン

Guidelines on the Clinical Evaluation of Medicinal Products for Treatment of Dyslipidemia

著者 (22件)： Yamashita Shizuya (Rinku General Medical Center) ,  Masuda Daisaku (Rinku General Medical Center) ,  Akishita Masahiro (Department of Geriatric Medicine, Graduate School of Medicine, the University of Tokyo) ,  Arai Hidenori (National Center for Geriatrics and Gerontology) ,  Asada Yujiro (Department of Pathology, Faculty of Medicine, University of Miyazaki) ,  Dobashi Kazushige (Department of Pediatrics, Enzan Citizen Hospital) ,  Egashira Kensuke (Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences) ,  Harada-Shiba Mariko (Department of Molecular Pathogenesis, National Cerebral and Cardiovascular Center Research Institute) ,  Hirata Kenichi (Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine) ,  Ishibashi Shun (Division of Endocrinology and Metabolism, Department of Medicine, Jichi Medical University) ,  Kajinami Kouji (Department of Cardiology, Kanazawa Medical University) ,  Kinoshita Makoto (Toray Industries, Inc.) ,  Kozaki Koichi (Department of Geriatric Medicine, Kyorin University School of Medicine) ,  Kuzuya Masafumi (Department of Community Healthcare and Geriatrics, Nagoya University Graduate School of Medicine) ,  Ogura Masatsune (Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute) ,  Okamura Tomonori (Preventive Medicine and Public Health, Keio University School of Medicine) ,  Sato Kayoko (Department of Cardiology, Tokyo Women’s Medical University) ,  Shimano Hitoshi (Department of Internal Medicine (Endocrinology and Metabolism), Faculty of Medicine, University of Tsukuba) ,  Tsukamoto Kazuhisa (Department of Internal Medicine, Teikyo University School of Medicine) ,  Yokode Masayuki (Department of Clinical Innovative Medicine, Kyoto University Graduate School of Medicine) ,  Yokote Koutaro (Department of Endocrinology, Hematology and Gerontology, Chiba University Graduate School of Medicin) ,  Yoshida Masayuki (Division of Medical Genetics, Medical Hospital of Tokyo Medical and Dental University)
資料名： Journal of Atherosclerosis and Thrombosis (Web)  (Journal of Atherosclerosis and Thrombosis (Web))
巻： 27  号： 11  ページ： 1246-1254(J-STAGE)  発行年： 2020年 
JST資料番号： U0153A  ISSN： 1880-3873  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： 日本 (JPN)  言語： 英語 (EN)

抄録/ポイント： ・日本動脈硬化学会により作成された,脂質低下薬の臨床評価に関...

シソーラス用語： ヒト ,...
準シソーラス用語： 有効性評価

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=21A0137873&from=J-GLOBAL&jstjournalNo=U0153A") }}

著者キーワード (6件)： ガイドライン ,  臨床評価 ,  医薬品製品 ,  脂質異常症の治療 ,  LDL-C ,  日本人

分類 (3件)： 代謝異常・栄養性疾患一般  (GD05010J) ,  研究開発  (GA01030U) ,  薬事,薬業  (GU01020R)

引用文献 (9件)：

• 1) Kinoshita M, Yokote K, Arai H, Iida M, Ishigaki Y, Ishibashi S, Seiji Umemoto S, Egusa G, Ohmura H, Okamura T, Kihara S, Koba S, Saito I, Shoji T, Daida H, Tsukamoto K, Deguchi J, Dohi S, Dobashi K, Hamaguchi H, Hara M, Hiro T, Biro S, Fujioka Y, Maruyama C, Miyamoto Y, Murakami Y, Yokode M, Yoshida H, Rakugi H, Wakatsuki A, Yamashita S, Committee for Epidemiology and Clinical Management of Atherosclerosis: Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017. J Atheroscler Thromb, 2018; 25: 846-984
• 2) Notification No.796 issued by Pharmaceutical and Medical Safety Bureau, Ministry of Health and Welfare. 2001. (in Japanese)
• 3) Guideline on drug interaction for drug development and appropriate provision of information. 2018. (in Japanese, MHLW, https://www.pmda.go.jp/rs-std-jp/standards-development/guidance-guideline/0001.html)
• 4) Kajinami K, Tsukamoto K, Koba S, Inoue I, Yamakawa M, Suzuki S, Hamano T, Saito H, Saito Y, Masuda S, Nakayama T, Okamura T, Yamashita S, Kagawa T, Kaneyama J, Kuriyama A, Tanaka R, Hirata A, Statin Intolerance Clinical Guide Working Group; The Japan Society of Hepatology, Japanese Society of Neurology, Japan Atherosclerosis Society, The Japanese Society for the Study of Xenobiotics: Statin intolerance clinical guide 2018. J Atheroscler Thromb, 2020; 27: 375-396
• 5) Satake S, Arai H: Chapter 1 Frailty: Definition, diagnosis, epidemiology. Geriatr Gerontol Int, 2020 Feb; 20 Suppl 1: 7-13

タイトルに関連する用語 (5件)： 脂質異常症 ,  治療 ,  医薬品 ,  臨床評価 ,  ガイドライン